Tumor Akkermansia muciniphila predicts clinical response to immune checkpoint inhibitors in non-small-cell lung cancer patients with low PD-L1 expression

Takashi Shimizu(Showa University), Toshiko Yamochi(Showa University)
Frontiers in Immunology
September 8, 2025
Cited by 3


Related Papers